Z

Zevra Therapeutics Inc
NASDAQ:ZVRA

Watchlist Manager
Zevra Therapeutics Inc
NASDAQ:ZVRA
Watchlist
Price: 9.03 USD 4.27% Market Closed
Market Cap: 475.2m USD
Have any thoughts about
Zevra Therapeutics Inc?
Write Note

Zevra Therapeutics Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zevra Therapeutics Inc
Retained Earnings Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zevra Therapeutics Inc
NASDAQ:ZVRA
Retained Earnings
-$436.3m
CAGR 3-Years
-18%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Retained Earnings
$155.2B
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
5%
Bristol-Myers Squibb Co
NYSE:BMY
Retained Earnings
$16.1B
CAGR 3-Years
-11%
CAGR 5-Years
-15%
CAGR 10-Years
-7%
Pfizer Inc
NYSE:PFE
Retained Earnings
$116.6B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
5%
Merck & Co Inc
NYSE:MRK
Retained Earnings
$61.4B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
4%
Eli Lilly and Co
NYSE:LLY
Retained Earnings
$13.6B
CAGR 3-Years
12%
CAGR 5-Years
22%
CAGR 10-Years
-2%

See Also

What is Zevra Therapeutics Inc's Retained Earnings?
Retained Earnings
-436.3m USD

Based on the financial report for Jun 30, 2024, Zevra Therapeutics Inc's Retained Earnings amounts to -436.3m USD.

What is Zevra Therapeutics Inc's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-12%

Over the last year, the Retained Earnings growth was -34%. The average annual Retained Earnings growth rates for Zevra Therapeutics Inc have been -18% over the past three years , -12% over the past five years .

Back to Top